In a sit-down interview after my onstage fireside chat with rival Cerner CEO David Feinberg at ViVE, Epic CEO Judith Faulkner aimed to set the record straight about Epic's capabilities in AI, interoperability as well as describe what developments she is excited about in healthcare.
A report detailed how Medicare Advantage grew again, gaining some of its numbers from new members and poaching others from Original Medicare, which is declining overall.
The FDA 510k-cleared Fist Assist FA-1 wearable device received Breakthrough Device designation late last year and the device maker is looking to raise capital through equity crowdfunding in May. Outside the U.S., it is approved for increased arm vein dilation and AV fistula dilation/maturation.
By Michael Schroeder Thursday, March 10, 2022 6:38 PM
The metric analyzes the influences of loneliness, social network quality, social capital and other data to deliver insights into how those factors converge to impact a community and the people living there, according to the company.
MorphoSys is cutting the drug discovery and R&D work of Constellation Pharmaceuticals, a company it acquired lats year in a $1.7 billion deal. This consolidation of research operations will result in non-cash impairment charge on Constellation's goodwill.
MedCity INVEST 2022 at The Ritz Carlton Chicago is a 3 day gathering with numerous opportunities for in-person networking and learning around the latest technologies and investment trends from VCs and successful entrepreneurs.
No comments